WEATHER UPDATE FEBRUARY 20. 2019

Rockville Office - Opening at 11am

Brandywine, Clinton, Lanham, Mt.Airy Offices Closed

Frederick Office Opening at 10am

 

 

 

USOR 17132

A PHASE III, MULTICENTER, RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB (ANTI PD-L1 ANTIBODY) AS ADJUVANT THERAPY AFTER DEFINITIVE LOCAL THERAPY IN PATIENTS WITH HIGH RISK LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Disease Types

Head and Neck

Available at

BethesdaBrandywineClintonColumbiaRockvilleSilver SpringWheaton

Contact

Linda Iovanni
MOHRSCH@usoncology.com